An economic analysis of drug eluting coronary stents: a Quebec perspective
Brophy J, Erickson L
Record ID 32004000872
English, French
Authors' objectives:
This report attempts to quantify the benefits and costs associated with drug eluting stent (DES) technology in order that informed resource allocation decisions may be made.
Authors' recommendations:
Irrespective of the level of financing adopted for DES, ethical considerations underpinning the universality of our health care system dictate that equally deserving patients should have equal access to this technology. This implies that this technology, at whatever designated level, should be available at all centres performing PCI and that similar selection criteria should be broadly applied to assure equal accessibility according to clinical need and not geographic location. It is also abundantly clear that an evaluation of the local results with DES is necessary to aid future decision-making regarding this technology. Details regarding the implantation of all coated stents should be recorded in a registry to facilitate this evaluation. The Agence d'Evaluation des technologies et des modes d'intervention en sante (AETMIS) and the Reseau quebcois de cardiologie tertiaire would appear to be ideal guarantors for this registry.
Authors' methods:
Economic evaluation
Details
Project Status:
Completed
URL for project:
http://www.aetmis.gouv.qc.ca/
Year Published:
2004
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Coronary Restenosis
- Costs and Cost Analysis
- Drug Delivery Systems
- Stents
Contact
Organisation Name:
Agence d'évaluation des technologies et des modes d'intervention en santé
Contact Address:
2021, avenue Union, Bureau 10.083,Montreal, Quebec H3A S29, Canada.Tel: +1 514 873 2563; Fax: +1 514 873 1369
Contact Name:
demande@inesss.qc.ca
Contact Email:
demande@inesss.qc.ca
Copyright:
Agence d'Evaluation des Technologies et des Modes d'Intervention en Sante (AETMIS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.